Company profile
Univec, Inc.
OTC: UNVC · Healthcare · Medical - Care Facilities
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 47
v0.1 · 5/100 weight · pillars only
↑ listing tenure, filing timeliness · ↓ Altman-Z, workforce scale
Methodology →Revenue TTM
$91.2k
Rev growth YoY (TTM)
+69.8%
Net income (FY)
—
Employees
3
as of 2026-09-21
Market cap
$5.4M
as of 2026-09-21
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Univec, Inc.’s financial profile?
Univec, Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
Cardiac Biotech Solutions Inc.——Acurx Pharmaceuticals, Inc.——Eastgate Biotech Corp.——Kairos Pharma, Ltd.——Liminatus Pharma, Inc. Class A Common Stock——Lakewood-Amedex Biotherapeutics Inc. Common Stock——Key facts
CEODavid Dalton
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersOwings Mills, MD
ExchangeOTC: UNVC
Employees3
IPO date1997-04-24
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.